As of 2024-12-12, the Fair Value of Kala Pharmaceuticals Inc (KALA) is -45.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.21 USD, the upside of Kala Pharmaceuticals Inc is -836.99%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -94.35 | -104.33 | -142.61 | -44.82 | -42.20 | -85.66 |
| YoY growth | -41.37% | -10.58% | -36.69% | 68.57% | 5.85% | -2.84% |
| Market Cap (mil) | 28.63 |
| P/E | |
| Forward P/E |
| EPS | -9.15 |
| Avg earnings growth rate | -2.84% |
| TTM earnings | -42.20 |